Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| United States Agency for International Development (USAID) | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Although research indicates that other characteristics of peanuts offset these properties, and that peanuts may be incorporated into diets without posing a threat to weight gain (Mattes et al., 2008), concern remains among policymakers, healthcare providers, and consumers. Furthermore, worry exists that eating salted peanuts may elevate blood pressure and that eating honey-roasted peanuts make elevate blood sugar. These fears create substantial obstacles to increased peanut consumption.
Recommendations to increase peanut consumption may be made, but if they are not followed, there will be no impact on health. Additional knowledge is needed on: (1) the acceptability of peanuts consumed on a chronic basis, (2) the chronic intake of moderate levels of peanuts and body weight, and 3) the effects of peanuts on blood pressure and blood sugar. The proposed research will examine the acceptability of long-term inclusion of a single form versus varied forms of peanuts in the diet. It is expected that responses will be varied among individuals with different personality characteristics (e.g., prefer sweet versus savory foods, hedonic versus non-hedonic eaters). A better understanding of how different segments of the population choose to include peanuts in their diet and how to optimize long-term consumption should provide insights for better marketing and improved health. Furthermore, it is anticipated that eating salty peanuts will not raise blood pressure and that eating honey-roasted peanuts will not raise blood sugar. Documenting this will add credibility to the evidence that peanuts do not cause weight gain, as well as reinforce recommendations to increase peanut consumption for their health benefits.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Consumption of 42 g of salted peanuts | Experimental | Consumption of 42 grams of peanuts daily |
|
| Consumption of 42 g of unsalted peanuts | Experimental | Consumption of 42 grams of peanuts daily |
|
| Consumption of 42 g of spicy peanuts | Experimental | Consumption of 42 grams of peanuts daily |
|
| Consumption of 42 g of honey peanuts | Experimental | Consumption of 42 grams of peanuts daily |
|
| Consumption of 42 g of 3 diff. varieties | Experimental | Consumption of 42 grams of peanuts daily |
|
| Consumption of 42 g of var. of types | Experimental |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Consumption of 42 grams of peanuts daily | Other | Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Weight | 2, 4, 6, 8, 10, and 12 weeks | |
| Change in Blood Lipids | 4, 8, and 12 weeks | |
| Change in Blood Pressure | 2, 4, 6, 8, 10, and 12 weeks | |
| Change in Hedonics of peanut consumption | Participants will rate their liking of the sample each day using a visual analog scale. | 12 weeks |
| Change in Body Composition | 2, 4, 6, 8, 10, and 12 weeks | |
| Change in Fasting Blood Glucose | 4, 8, and 12 weeks | |
| Change in Cortisol | 4, 8, and 12 weeks | |
| Change in Insulin | 4, 8, and 12 weeks | |
| Change in Pulse | 2, 4, 6, 8, 10, and 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Personality Questionnaires | At baseline visit | |
| Flavor attribute liking measures | At baseline | |
| Compliance |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard D Mattes, RD, MPH, PhD | Purdue University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Purdue University | West Lafayette | Indiana | 47907 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25064672 | Derived | Jones JB, Provost M, Keaver L, Breen C, Ludy MJ, Mattes RD. Effects of daily consumption of one or varied peanut flavors on acceptance and intake. Appetite. 2014 Nov;82:208-12. doi: 10.1016/j.appet.2014.07.023. Epub 2014 Jul 23. | |
| 24351876 | Derived | Jones JB, Provost M, Keaver L, Breen C, Ludy MJ, Mattes RD. A randomized trial on the effects of flavorings on the health benefits of daily peanut consumption. Am J Clin Nutr. 2014 Mar;99(3):490-6. doi: 10.3945/ajcn.113.069401. Epub 2013 Dec 18. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D006949 | Hyperlipidemias |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Consumption of 42 grams of peanuts daily |
|
Participants will self-report compliance to study protocol using record sheets. |
| 12 weeks |
| Appetitive Ratings | Collected on handheld computer | 4, 8, and 12 weeks |
| Consumption Parameters | Participants will note if peanuts were eaten as a meal or snack, at what time, and with what other foods daily. | 12 weeks |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |